Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10).

AML additional chromosomal abnormalities allogeneic hematopoietic stem cell transplantation der(1;7)(q10;p10)

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 13 10 2022
accepted: 20 10 2022
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

The prognosis of acute myeloid leukemia (AML) patients with der(1;7)(q10;p10) who underwent allogeneic hematopoietic stem cell transplantation (allo-SCT) is unclear due to its rarity. We retrospectively analyzed 151 AML patients with der(1;7)(q10;p10) and compared the findings with those of 853 AML patients with monosomy 7 or chromosome 7q deletion (-7/del(7q)) using Japanese nationwide registry data. The der(1;7)(q10;p10) group showed significantly better transplant outcomes than the -7/del(7q) group. In the multivariate analysis of the der(1;7)(q10;p10) group, additional chromosomal abnormalities and a poor performance status significantly influenced the survival. In conclusion, allo-SCT is a feasible treatment option for AML patients with der(1;7)(q10;p10).

Identifiants

pubmed: 36819182
doi: 10.1002/jha2.609
pii: JHA2609
pmc: PMC9928652
doi:

Types de publication

Journal Article

Langues

eng

Pagination

251-257

Informations de copyright

© 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no competing financial interests.

Références

Leukemia. 2007 May;21(5):992-7
pubmed: 17315020
Genes Chromosomes Cancer. 2019 Oct;58(10):689-697
pubmed: 30994215
Cancer Genet Cytogenet. 2006 Mar;165(2):161-6
pubmed: 16527611
Blood. 2010 Jul 22;116(3):354-65
pubmed: 20385793
Bone Marrow Transplant. 2019 Sep;54(9):1471-1481
pubmed: 30718803
Blood. 2021 Dec 9;138(23):2441-2445
pubmed: 34469508
Am J Hematol. 2012 Jul;87(7):684-6
pubmed: 22565657
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Int J Hematol. 2016 Jan;103(1):11-9
pubmed: 26588927
Int J Hematol. 2016 Jan;103(1):3-10
pubmed: 26547570
Biol Blood Marrow Transplant. 2012 Feb;18(2):280-8
pubmed: 21810400
Leukemia. 2017 Oct;31(10):2257-2260
pubmed: 28720763
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058

Auteurs

Hiroki Mizumaki (H)

Department of Hematology Kanazawa University Hospital Kanazawa Japan.

Ken Ishiyama (K)

Department of Hematology Kanazawa University Hospital Kanazawa Japan.

Jun Aoki (J)

Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan.

Jinichi Mori (J)

Department of Hematology Jyoban Hospital of Tokiwa Foundation Fukushima Japan.

Shohei Mizuno (S)

Division of Hematology Department of Internal Medicine Aichi Medical University Nagakute Japan.

Noriko Doki (N)

Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.

Takahiro Fukuda (T)

Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan.

Naoyuki Uchida (N)

Department of Hematology Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital Tokyo Japan.

Masahito Onizuka (M)

Department of Hematology and Oncology Tokai University School of Medicine Isehara Japan.

Masatsugu Tanaka (M)

Department of Hematology Kanagawa Cancer Center Yokohama Japan.

Yuta Katayama (Y)

Department of Hematology Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital Hiroshima Japan.

Yukiyasu Ozawa (Y)

Department of Hematology Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital Nagoya Japan.

Kazuhiro Ikegame (K)

Department of Hematology Hyogo Medical University Hospital Hyogo Japan.

Satoru Takada (S)

Leukemia Research Center Saiseikai Maebashi Hospital Maebashi Japan.

Toshiro Kawakita (T)

Department of Hematology National Hospital Organization Kumamoto Medical Center Kumamoto Japan.

Nobuyuki Aotsuka (N)

Division of Hematology-Oncology Japanese Red Cross Society Narita Hospital Narita Japan.

Yoshiko Atsuta (Y)

Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan.
Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Nagakute Japan.

Masamitsu Yanada (M)

Department of Hematology and Cell Therapy Aichi Cancer Center Nagoya Japan.

Classifications MeSH